Hubei Guangji Pharmaceutical Co Ltd (000952) — Free Cash Flow Generation Index
Hubei Guangji Pharmaceutical Co Ltd (000952) has a Free Cash Flow Generation Index of 0.61x as of September 2025. Free cash flow of CN¥13.71 Million represents 1% of operating cash flow (CN¥22.38 Million). Read total liabilities of Hubei Guangji Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hubei Guangji Pharmaceutical Co Ltd Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Hubei Guangji Pharmaceutical Co Ltd across 20 annual periods. Explore Hubei Guangji Pharmaceutical Co Ltd (000952) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Hubei Guangji Pharmaceutical Co Ltd (1999–2025)
Year-by-year Free Cash Flow Generation Index for Hubei Guangji Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Hubei Guangji Pharmaceutical Co Ltd.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | CN¥24.79 Million | CN¥60.43 Million | CN¥35.64 Million | ▲ +100.2% |
| 2024 | -235.41x | CN¥-154.28 Million | CN¥655.36K | CN¥154.93 Million | ▼ -6590.0% |
| 2022 | -3.52x | CN¥-158.63 Million | CN¥45.08 Million | CN¥203.71 Million | ▼ -1190.4% |
| 2021 | -0.27x | CN¥-20.70 Million | CN¥75.91 Million | CN¥96.61 Million | ▼ -251.5% |
| 2020 | 0.18x | CN¥21.49 Million | CN¥119.38 Million | CN¥97.89 Million | ▲ +6.2% |
| 2019 | 0.17x | CN¥24.44 Million | CN¥144.20 Million | CN¥119.76 Million | ▼ -74.7% |
| 2018 | 0.67x | CN¥154.91 Million | CN¥231.44 Million | CN¥76.53 Million | ▲ +22.2% |
| 2017 | 0.55x | CN¥97.92 Million | CN¥178.83 Million | CN¥80.91 Million | ▲ +69.0% |
| 2016 | 0.32x | CN¥54.13 Million | CN¥167.07 Million | CN¥112.94 Million | ▼ -31.7% |
| 2013 | 0.47x | CN¥45.12 Million | CN¥95.16 Million | CN¥50.04 Million | ▲ +642.6% |
| 2012 | -0.09x | CN¥-9.44 Million | CN¥108.02 Million | CN¥117.46 Million | ▲ +94.0% |
| 2011 | -1.45x | CN¥-119.08 Million | CN¥81.88 Million | CN¥200.96 Million | ▼ -192.4% |
| 2010 | -0.50x | CN¥-38.39 Million | CN¥77.18 Million | CN¥115.57 Million | ▼ -11809.9% |
| 2008 | 0.00x | CN¥937.45K | CN¥220.70 Million | CN¥219.76 Million | ▼ -99.5% |
| 2007 | 0.85x | CN¥283.03 Million | CN¥331.98 Million | CN¥48.94 Million | ▲ +0.1% |
| 2006 | 0.85x | CN¥107.23 Million | CN¥125.95 Million | CN¥18.73 Million | ▲ +62.9% |
| 2005 | 0.52x | CN¥28.30 Million | CN¥54.14 Million | CN¥25.84 Million | ▲ +55.1% |
| 2002 | 0.34x | CN¥25.68 Million | CN¥76.20 Million | CN¥50.52 Million | ▼ -30.2% |
| 2000 | 0.48x | CN¥23.46 Million | CN¥48.57 Million | CN¥25.11 Million | ▲ +149.4% |
| 1999 | -0.98x | CN¥-67.01 Million | CN¥68.57 Million | CN¥135.58 Million | — |